Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 30 | 2023 | 1965 | 4.320 |
Why?
|
Heart Valve Prosthesis Implantation | 20 | 2023 | 1536 | 3.000 |
Why?
|
Aortic Valve | 22 | 2023 | 1922 | 2.310 |
Why?
|
Shock, Cardiogenic | 12 | 2023 | 688 | 1.900 |
Why?
|
Myocardial Infarction | 26 | 2023 | 11727 | 1.850 |
Why?
|
Mitral Valve Insufficiency | 9 | 2023 | 1422 | 1.690 |
Why?
|
Patient Readmission | 20 | 2023 | 3114 | 1.610 |
Why?
|
Plasma Kallikrein | 3 | 2016 | 20 | 1.380 |
Why?
|
Ischemic Attack, Transient | 3 | 2023 | 935 | 1.270 |
Why?
|
Hospital Mortality | 47 | 2021 | 5317 | 1.260 |
Why?
|
Myocardial Revascularization | 6 | 2020 | 841 | 1.020 |
Why?
|
Cardiovascular Agents | 5 | 2020 | 850 | 1.010 |
Why?
|
Hospital Costs | 14 | 2021 | 985 | 0.930 |
Why?
|
Inpatients | 18 | 2020 | 2518 | 0.870 |
Why?
|
Ischemia | 3 | 2021 | 1907 | 0.840 |
Why?
|
Endovascular Procedures | 7 | 2020 | 1979 | 0.840 |
Why?
|
Myocardial Ischemia | 7 | 2023 | 2148 | 0.810 |
Why?
|
Postoperative Complications | 18 | 2022 | 15295 | 0.800 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 42 | 0.770 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 223 | 0.770 |
Why?
|
Vascular Grafting | 2 | 2020 | 142 | 0.770 |
Why?
|
Treatment Outcome | 68 | 2023 | 63114 | 0.740 |
Why?
|
Tricuspid Valve | 2 | 2020 | 403 | 0.730 |
Why?
|
Registries | 12 | 2023 | 8089 | 0.710 |
Why?
|
Mitral Valve | 9 | 2023 | 1491 | 0.710 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1188 | 0.700 |
Why?
|
Acute Coronary Syndrome | 4 | 2021 | 2337 | 0.700 |
Why?
|
Intracranial Embolism | 1 | 2021 | 202 | 0.700 |
Why?
|
Plaque, Atherosclerotic | 2 | 2021 | 1519 | 0.690 |
Why?
|
Databases, Factual | 23 | 2021 | 7729 | 0.690 |
Why?
|
Risk Factors | 69 | 2023 | 72290 | 0.680 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 269 | 0.670 |
Why?
|
Peripartum Period | 2 | 2017 | 133 | 0.670 |
Why?
|
Coronary Artery Bypass | 9 | 2021 | 2289 | 0.660 |
Why?
|
Heart Failure | 9 | 2022 | 10900 | 0.660 |
Why?
|
United States | 72 | 2023 | 69872 | 0.650 |
Why?
|
Propensity Score | 10 | 2021 | 1781 | 0.640 |
Why?
|
Antithrombins | 1 | 2021 | 304 | 0.630 |
Why?
|
Cardiology | 5 | 2023 | 1668 | 0.630 |
Why?
|
Aminopyridines | 2 | 2012 | 542 | 0.620 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1073 | 0.610 |
Why?
|
Aged, 80 and over | 50 | 2023 | 57776 | 0.610 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2018 | 264 | 0.600 |
Why?
|
Catheterization, Peripheral | 2 | 2022 | 345 | 0.600 |
Why?
|
Time Factors | 42 | 2021 | 40075 | 0.600 |
Why?
|
Atrial Appendage | 4 | 2021 | 283 | 0.580 |
Why?
|
Heart Valve Prosthesis | 7 | 2020 | 1488 | 0.580 |
Why?
|
Risk Assessment | 29 | 2020 | 23338 | 0.580 |
Why?
|
Incidence | 30 | 2022 | 20947 | 0.560 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2020 | 2073 | 0.550 |
Why?
|
Malnutrition | 1 | 2022 | 625 | 0.540 |
Why?
|
Radial Artery | 2 | 2022 | 194 | 0.540 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2014 | 219 | 0.540 |
Why?
|
Length of Stay | 21 | 2021 | 6309 | 0.540 |
Why?
|
Drug-Eluting Stents | 3 | 2018 | 753 | 0.530 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2019 | 349 | 0.530 |
Why?
|
Puerperal Disorders | 2 | 2017 | 275 | 0.520 |
Why?
|
Aged | 81 | 2023 | 163280 | 0.520 |
Why?
|
Humans | 153 | 2023 | 744343 | 0.520 |
Why?
|
Specialty Boards | 1 | 2017 | 227 | 0.520 |
Why?
|
Cardiovascular Diseases | 9 | 2021 | 15165 | 0.520 |
Why?
|
Stroke | 12 | 2023 | 9981 | 0.510 |
Why?
|
Kininogen, High-Molecular-Weight | 2 | 2011 | 6 | 0.510 |
Why?
|
Hospitals | 5 | 2021 | 3952 | 0.510 |
Why?
|
Extremities | 2 | 2021 | 865 | 0.490 |
Why?
|
Coronary Angiography | 8 | 2021 | 4577 | 0.490 |
Why?
|
Endocarditis | 1 | 2018 | 350 | 0.480 |
Why?
|
Odds Ratio | 16 | 2021 | 9849 | 0.470 |
Why?
|
Heart Aneurysm | 1 | 2014 | 120 | 0.460 |
Why?
|
Certification | 1 | 2017 | 424 | 0.460 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 500 | 0.460 |
Why?
|
Heart Arrest | 4 | 2017 | 1470 | 0.450 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1972 | 0.450 |
Why?
|
Femoral Artery | 2 | 2022 | 845 | 0.450 |
Why?
|
Saphenous Vein | 1 | 2016 | 532 | 0.430 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 538 | 0.430 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 549 | 0.420 |
Why?
|
Hospitalization | 9 | 2021 | 10262 | 0.420 |
Why?
|
Male | 97 | 2023 | 350118 | 0.410 |
Why?
|
Retrospective Studies | 53 | 2022 | 77449 | 0.410 |
Why?
|
Survival Rate | 18 | 2019 | 12788 | 0.410 |
Why?
|
Septal Occluder Device | 3 | 2021 | 128 | 0.410 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1912 | 0.410 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2011 | 24 | 0.400 |
Why?
|
Patient Discharge | 9 | 2021 | 3313 | 0.390 |
Why?
|
Female | 96 | 2023 | 380194 | 0.390 |
Why?
|
Patient Care Team | 2 | 2020 | 2531 | 0.390 |
Why?
|
Skilled Nursing Facilities | 4 | 2021 | 372 | 0.380 |
Why?
|
Magnesium | 1 | 2014 | 813 | 0.380 |
Why?
|
Cardiac Surgical Procedures | 2 | 2023 | 3537 | 0.380 |
Why?
|
Forecasting | 2 | 2018 | 2951 | 0.370 |
Why?
|
Electrocardiography | 9 | 2018 | 6442 | 0.350 |
Why?
|
Angina, Unstable | 1 | 2013 | 926 | 0.340 |
Why?
|
Cardiotonic Agents | 2 | 2015 | 535 | 0.340 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2657 | 0.330 |
Why?
|
Coronary Artery Disease | 6 | 2020 | 6487 | 0.330 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.320 |
Why?
|
Atrial Fibrillation | 7 | 2022 | 5034 | 0.310 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2019 | 97 | 0.310 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 851 | 0.310 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3508 | 0.310 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1537 | 0.300 |
Why?
|
Lipopolysaccharides | 2 | 2012 | 2216 | 0.300 |
Why?
|
Middle Aged | 55 | 2021 | 213383 | 0.300 |
Why?
|
Contrast Media | 2 | 2020 | 5300 | 0.290 |
Why?
|
Logistic Models | 11 | 2021 | 13408 | 0.290 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3610 | 0.280 |
Why?
|
Blood Coagulation | 1 | 2012 | 1127 | 0.280 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 2 | 2020 | 131 | 0.270 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2021 | 2208 | 0.270 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 579 | 0.260 |
Why?
|
Erythrocyte Transfusion | 2 | 2020 | 565 | 0.250 |
Why?
|
Comorbidity | 12 | 2021 | 10388 | 0.250 |
Why?
|
Cause of Death | 6 | 2021 | 3584 | 0.250 |
Why?
|
Cardiomyopathies | 4 | 2018 | 1912 | 0.240 |
Why?
|
Morbidity | 6 | 2019 | 1769 | 0.240 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2020 | 1265 | 0.240 |
Why?
|
Influenza, Human | 3 | 2021 | 1479 | 0.240 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3798 | 0.240 |
Why?
|
Disease Management | 3 | 2021 | 2459 | 0.220 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1889 | 0.220 |
Why?
|
International Classification of Diseases | 2 | 2021 | 867 | 0.220 |
Why?
|
Secondary Prevention | 2 | 2021 | 1530 | 0.210 |
Why?
|
American Heart Association | 3 | 2023 | 1056 | 0.210 |
Why?
|
Pacemaker, Artificial | 2 | 2020 | 816 | 0.210 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2018 | 789 | 0.200 |
Why?
|
Follow-Up Studies | 16 | 2021 | 39050 | 0.200 |
Why?
|
Endothelial Cells | 2 | 2011 | 3479 | 0.200 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.200 |
Why?
|
Kidney Failure, Chronic | 4 | 2018 | 2538 | 0.200 |
Why?
|
Cost of Illness | 4 | 2020 | 1859 | 0.190 |
Why?
|
Atrial Septum | 1 | 2021 | 60 | 0.190 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3670 | 0.190 |
Why?
|
Epoprostenol | 2 | 2011 | 254 | 0.180 |
Why?
|
Renal Dialysis | 3 | 2018 | 1786 | 0.180 |
Why?
|
Multivariate Analysis | 7 | 2021 | 12245 | 0.180 |
Why?
|
Age Factors | 8 | 2021 | 18370 | 0.180 |
Why?
|
Coronary Vessels | 2 | 2021 | 3107 | 0.180 |
Why?
|
Sepsis | 2 | 2021 | 2593 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1240 | 0.170 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 45 | 0.170 |
Why?
|
Hypertension | 5 | 2021 | 8480 | 0.170 |
Why?
|
Nutrition Assessment | 1 | 2022 | 723 | 0.170 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2017 | 980 | 0.170 |
Why?
|
Sex Factors | 6 | 2021 | 10397 | 0.160 |
Why?
|
Stents | 2 | 2021 | 3280 | 0.160 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 248 | 0.160 |
Why?
|
Coronary Disease | 2 | 2023 | 6077 | 0.160 |
Why?
|
Mitral Valve Prolapse | 1 | 2020 | 231 | 0.160 |
Why?
|
Renal Artery | 1 | 2020 | 398 | 0.150 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 194 | 0.150 |
Why?
|
Death | 1 | 2022 | 678 | 0.150 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1671 | 0.150 |
Why?
|
Tachycardia, Ventricular | 2 | 2018 | 1273 | 0.150 |
Why?
|
Prevalence | 9 | 2021 | 15226 | 0.150 |
Why?
|
Denmark | 1 | 2019 | 738 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 361 | 0.150 |
Why?
|
Hemorrhage | 5 | 2023 | 3461 | 0.150 |
Why?
|
Endarterectomy | 1 | 2017 | 195 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 9959 | 0.150 |
Why?
|
Echocardiography | 4 | 2019 | 5102 | 0.150 |
Why?
|
Patient Admission | 2 | 2015 | 1380 | 0.140 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2018 | 96 | 0.140 |
Why?
|
New Mexico | 1 | 2016 | 86 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2021 | 1179 | 0.140 |
Why?
|
Antigens, CD34 | 1 | 2018 | 657 | 0.140 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 634 | 0.130 |
Why?
|
Rhode Island | 1 | 2016 | 347 | 0.130 |
Why?
|
Heart-Assist Devices | 2 | 2017 | 1194 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15540 | 0.130 |
Why?
|
Rural Population | 2 | 2022 | 2210 | 0.130 |
Why?
|
Prognosis | 8 | 2019 | 29063 | 0.130 |
Why?
|
Punctures | 1 | 2016 | 374 | 0.130 |
Why?
|
Bioprosthesis | 1 | 2019 | 596 | 0.130 |
Why?
|
Health Status Disparities | 4 | 2020 | 1797 | 0.120 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 488 | 0.120 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 47 | 0.120 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4251 | 0.120 |
Why?
|
Nutritional Status | 1 | 2022 | 1609 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 977 | 0.120 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1206 | 0.120 |
Why?
|
Exercise Test | 1 | 2021 | 2074 | 0.120 |
Why?
|
Coronary Circulation | 1 | 2020 | 1572 | 0.120 |
Why?
|
Medicaid | 2 | 2018 | 2736 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 173 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 742 | 0.110 |
Why?
|
Stroke Volume | 2 | 2023 | 5007 | 0.110 |
Why?
|
Acetanilides | 1 | 2014 | 168 | 0.110 |
Why?
|
Patient Transfer | 2 | 2018 | 761 | 0.110 |
Why?
|
Catheter Ablation | 2 | 2018 | 2758 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6489 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2019 | 1301 | 0.110 |
Why?
|
Carotid Stenosis | 1 | 2020 | 854 | 0.110 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2023 | 285 | 0.110 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1133 | 0.110 |
Why?
|
Drug Costs | 1 | 2020 | 1105 | 0.110 |
Why?
|
Age Distribution | 4 | 2020 | 2902 | 0.110 |
Why?
|
Sex Distribution | 4 | 2018 | 2297 | 0.110 |
Why?
|
Quality Improvement | 2 | 2019 | 3749 | 0.100 |
Why?
|
Nitric Oxide | 2 | 2011 | 2132 | 0.100 |
Why?
|
Prekallikrein | 1 | 2011 | 11 | 0.100 |
Why?
|
Blood Coagulation Disorders | 1 | 2015 | 337 | 0.100 |
Why?
|
Kidney | 2 | 2017 | 7186 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 455 | 0.100 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2012 | 188 | 0.100 |
Why?
|
Maternal Mortality | 1 | 2014 | 310 | 0.100 |
Why?
|
Emergencies | 1 | 2018 | 1170 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 429 | 0.100 |
Why?
|
Hemodynamics | 2 | 2020 | 4199 | 0.100 |
Why?
|
Drug Combinations | 1 | 2016 | 1959 | 0.100 |
Why?
|
Signal Transduction | 2 | 2011 | 23403 | 0.100 |
Why?
|
Calcinosis | 1 | 2020 | 1499 | 0.100 |
Why?
|
Health Resources | 1 | 2017 | 911 | 0.100 |
Why?
|
Bradykinin | 1 | 2011 | 214 | 0.100 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1351 | 0.100 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1440 | 0.100 |
Why?
|
Adult | 22 | 2021 | 214055 | 0.090 |
Why?
|
Creatinine | 1 | 2016 | 1919 | 0.090 |
Why?
|
Verapamil | 1 | 2011 | 244 | 0.090 |
Why?
|
Cohort Studies | 4 | 2022 | 40561 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2017 | 834 | 0.090 |
Why?
|
Smoking | 3 | 2021 | 8987 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 603 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1184 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5391 | 0.090 |
Why?
|
Phenylephrine | 1 | 2011 | 301 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1095 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2788 | 0.090 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 687 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1475 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1956 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15076 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1620 | 0.090 |
Why?
|
Heart Conduction System | 1 | 2015 | 1047 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2170 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10943 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1928 | 0.080 |
Why?
|
Recurrence | 2 | 2018 | 8340 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1167 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 1107 | 0.080 |
Why?
|
Home Care Services | 1 | 2015 | 606 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.080 |
Why?
|
Peripheral Vascular Diseases | 2 | 2021 | 550 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2020 | 1620 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1541 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4599 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2018 | 1683 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1801 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2015 | 1354 | 0.070 |
Why?
|
Nursing Homes | 1 | 2014 | 1036 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2011 | 977 | 0.070 |
Why?
|
Obesity | 3 | 2021 | 12745 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2376 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7659 | 0.070 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5751 | 0.070 |
Why?
|
Gadolinium | 1 | 2011 | 952 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3158 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2011 | 1240 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2149 | 0.070 |
Why?
|
Rabbits | 1 | 2012 | 4894 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2400 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2011 | 19229 | 0.060 |
Why?
|
Rats | 2 | 2012 | 24260 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3567 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3265 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3493 | 0.060 |
Why?
|
Heart Transplantation | 2 | 2015 | 3110 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18029 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2268 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4371 | 0.060 |
Why?
|
Pregnancy | 2 | 2017 | 29144 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2795 | 0.060 |
Why?
|
Young Adult | 7 | 2022 | 56430 | 0.060 |
Why?
|
Thrombosis | 2 | 2021 | 2968 | 0.060 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.060 |
Why?
|
Plasmapheresis | 2 | 2015 | 211 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3340 | 0.060 |
Why?
|
Kinetics | 1 | 2011 | 6473 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2021 | 3240 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4456 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 282 | 0.050 |
Why?
|
Health Status | 3 | 2020 | 4034 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 85781 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8301 | 0.050 |
Why?
|
Chronic Disease | 3 | 2023 | 9146 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3843 | 0.050 |
Why?
|
Superinfection | 1 | 2021 | 65 | 0.050 |
Why?
|
Software | 1 | 2015 | 4443 | 0.050 |
Why?
|
Learning Curve | 1 | 2021 | 208 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 214 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4933 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4584 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4468 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 309 | 0.040 |
Why?
|
Mortality | 2 | 2022 | 2864 | 0.040 |
Why?
|
Splanchnic Circulation | 1 | 2019 | 110 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 322 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5952 | 0.040 |
Why?
|
Calcium | 1 | 2011 | 5756 | 0.040 |
Why?
|
Medicare | 1 | 2015 | 6566 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.030 |
Why?
|
Normal Distribution | 1 | 2017 | 280 | 0.030 |
Why?
|
Animals | 3 | 2014 | 168757 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 2017 | 351 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2017 | 498 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 789 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 475 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
Endarterectomy, Carotid | 1 | 2020 | 546 | 0.030 |
Why?
|
Dobutamine | 1 | 2015 | 123 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5788 | 0.030 |
Why?
|
Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1359 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2021 | 906 | 0.030 |
Why?
|
India | 1 | 2021 | 2197 | 0.030 |
Why?
|
Systole | 1 | 2017 | 958 | 0.030 |
Why?
|
Radiation Protection | 1 | 2017 | 419 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 2015 | 176 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 950 | 0.030 |
Why?
|
Shock, Septic | 1 | 2021 | 775 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1180 | 0.030 |
Why?
|
New York | 1 | 2016 | 886 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2021 | 849 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 623 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2015 | 387 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2018 | 770 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2124 | 0.030 |
Why?
|
Hospital Charges | 1 | 2015 | 362 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1504 | 0.030 |
Why?
|
Nitrates | 1 | 2014 | 265 | 0.030 |
Why?
|
Utilization Review | 1 | 2014 | 392 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1681 | 0.030 |
Why?
|
Cost Savings | 1 | 2017 | 926 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.030 |
Why?
|
Uncertainty | 1 | 2017 | 734 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1254 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 413 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 855 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 690 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 968 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 652 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2569 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1850 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2242 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2494 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3528 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4215 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2971 | 0.020 |
Why?
|
Disabled Persons | 1 | 2018 | 1212 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2925 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 964 | 0.020 |
Why?
|
Body Mass Index | 2 | 2016 | 12720 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1637 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1114 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4037 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3278 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1303 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
Warfarin | 1 | 2015 | 1496 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7785 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3821 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4149 | 0.010 |
Why?
|
Critical Care | 1 | 2014 | 2647 | 0.010 |
Why?
|
Blood Pressure | 1 | 2017 | 8554 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12804 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41006 | 0.010 |
Why?
|
Child | 1 | 2018 | 77709 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|